The concept of cancer genetics is relatively new and considered more in prostate and breast cancer. Its role in OSCC has never been given much attention, which is the sixth most common malignancy worldwide. It is a tumour which can be treated by simple surgical procedure, if diagnosed at an early stage. Oral cavity and oropharynx are easily accessible for visualization. But high prevalence of oral abnormalities (5-15%) detected as a result of oral screening programmes (OSP) subjects large number of patients for biopsy which is impractical. Detection of early stage oral cancer is significantly impaired by absence of classic clinical characteristics of advanced oral cancer in early stage lesions. This influences 5 year survival rate for 80% of patients, despite major advances in surgery, chemotherapy, radiotherapy.
Many gene alterations have been implicated in development and progression of OSCC. Genetic differences is an important consideration to determine individual differences in susceptibility to chemical carcinogens. Many genetic changes are commonly observed in oral cancers. Salivary Transcriptome Diagnostics, based on specific mRNA signature in saliva as diagnostic marker, can be a suitable tool for development of non invasive diagnostic, chemoprevention, prognostic and follow up tests for cancer and also to detect cancer conversion of premalignant lesions. To summarize research on genetics will open new directions for estimation of risk of human cancer and its early diagnosis. 
GENETICS -Role in prevention and control of OSCC
Cancer can be prevented or controlled through interference with factors which cause initiation, promotion or progression Smoking cessation does not markedly decrease the cured patients risk of second malignancy (5) It may halt the early stages of carcinogenesis (metaplasia), but has no effect on late stages Thus, work has to be done on genetics for prevention and control of OSCC Chromosomal alterations provide important clue to genetic changes in cancer and can lead to mechanical based design and development of new generation of cancer drugs Knowledge of molecular events governing cell cycle regulation, has lead to development of Oncolytic viruses, designed to replicate in tumour cells (which lack p53 pathway) These are Adenoviruses mutant lacking viral p55 protein and has demonstrated efficacy especially when combined with 5-Fluorouracil and cisplatin(1)
Summary and Conclusion
Cancer develops through an interaction between genetic and environmental exposures. Much work has been done on its prevention and control, with no stress on early detection. Primary prevention concerns the identification and manipulation of genetic, biologic and environmental factors in casual pathway. Secondary prevention concerns identification of asymptomatic neoplastic lesions combined with effective therapy. But, detecting cancer in asymptomatic individuals can save lives. A number of genes have been identified that predispose for cancer. Testing for these genes can define a high risk population, which are ideal candidates for chemoprevention and intensive screening. Thus, primary and secondary prevention, if combined with early detection, can be effective tool to decrease morbidity and mortality and to improve diagnosis and prognosis of OSCC.
